Saluda Medical starts US commercialization of spinal cord stimulation system

Spinal Tech

Saluda Medical initiated the U.S. commercialization of the Evoke spinal cord stimulator, the devicemaker said Dec. 15.

Evoke is the only FDA-approved therapy with 24-month follow-up from a clinical study, according to a news release. A full commercial release is scheduled for 2023.

Evoke uses closed-loop technology and is designedto treat trunk and/or limb pain. The device earned FDA approval in March.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers